Home2162 • HKG
add
Keymed Biosciences Inc
Previous close
$41.50
Day range
$40.45 - $44.55
Year range
$27.05 - $49.60
Market cap
12.25B HKD
Avg Volume
1.82M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 186.72M | 1,284.61% |
Operating expense | 298.81M | 35.17% |
Net income | -89.25M | 56.07% |
Net profit margin | -47.80 | 96.83% |
Earnings per share | — | — |
EBITDA | -97.64M | 51.65% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.16B | -20.73% |
Total assets | 3.77B | -3.00% |
Total liabilities | 1.29B | 44.11% |
Total equity | 2.48B | — |
Shares outstanding | 275.60M | — |
Price to book | 4.62 | — |
Return on assets | -7.72% | — |
Return on capital | -9.01% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -89.25M | 56.07% |
Cash from operations | -211.86M | -23.44% |
Cash from investing | 53.78M | 350.02% |
Cash from financing | 9.99M | -73.74% |
Net change in cash | -145.75M | -10.35% |
Free cash flow | -96.66M | 43.81% |
About
CEO
Founded
Sep 2016
Website
Employees
1,258
